Mindray Launches New BeneFusion e Series Infusion Systems, Delivering Efficiency in Every Droplet

SHENZHEN, China, Feb. 2, 2021 /PRNewswire/ — Mindray (SZSE: 300760), a global leader in the development of innovative healthcare technology, has unveiled its BeneFusion e Series, a revolutionary efficient infusion system for the healthcare industry. Available in three models, eSP, eVP and eDS, the BeneFusion e Series delivers efficiency in workflow, safety, application and informatics. […]

Mindray Launches New BeneFusion e Series Infusion Systems, Delivering Efficiency in Every Droplet

SHENZHEN, China, Feb. 2, 2021 /PRNewswire/ — Mindray (SZSE: 300760), a global leader in the development of innovative healthcare technology, has unveiled its BeneFusion e Series, a revolutionary efficient infusion system for the healthcare industry. Available in three models, eSP, eVP and eDS, the BeneFusion e Series delivers efficiency in workflow, safety, application and informatics. […]

Nyxoah and Vanderbilt University enter exclusive licensing agreement regarding next generation neurostimulation technologies to treat Obstructive Sleep Apnea (OSA)

Mont-Saint-Guibert, Belgium – 2nd February, 2021 – Nyxoah SA (Euronext: NYXH) (“Nyxoah” or the “Company”), a health-technology company focused on the development and commercialization of innovative solutions and services to treat Obstructive Sleep Apnea (OSA), today announces the Company has signed an exclusive license agreement with Vandebilt University, Nashville – TN, USA. The agreement allows […]